Novālent is HACCP Certified

December 9, 2020

Novālent reports its facilities are Hazard Analysis Critical Control Point (HACCP) certified.

“Earning the GMP/HACCP certification in our manufacturing plant is a competitive advantage. This is a big deal when it comes to adding another layer of food safety for our food and beverage customers. In today’s world where there is a heightened awareness for food protection, this certification becomes extremely valuable to the entire food chain.” Mike Motta, Chief Commercial Officer at Novālent, explains.

HACCP certification is an internationally recognized list of requirements established by the Food Safety Modernization Act (FSMA) and Global Food Safety Initiatives (GFSI) standards.

Achieving the certification confirms a company employs effective control of food safety throughout its processes. The principles of this certification are often used to update food safety legislation in countries around the world.

Novālent was assisted in this achievement by Darryle Guarino, CEO at GFSC Group, Inc. who says going through this process is indicative of a modern biochemical company’s dedication to safety.

“Spending time on this certification—and it is a significant time and resources investment—is indicative of a company seeking to modernize its approach to food safety requirements.”

Novālent film technology is for use as a residual antimicrobial under EPA and FDA regulations to preserve food contact surfaces and is used by leading firms including PepsiCo, Sabra, and Pilgrims. Novālent antimicrobial creates an invisible film that stays active and anchored through day to day operations. One application lasts up to 90 days and through multiple cleaning cycles. The company also offers a hand sanitizer.

SourceNovālent

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”